Upcoming Fda Approvals 2025 Calendar

Upcoming Fda Approvals 2025 Calendar. Upcoming fda approval decisions in q1 2025 nat rev drug discov. Our enhanced fda calendar integrates pdufa dates, clinical trial primary completion dates, and working capital runway estimates into a single timeline that covers companies publicly traded in the u.s.

But due to the nature of a medication’s expected impact, some new fda approvals represent especially meaningful steps forward. Upcoming fda approvals for 2024 include lebrikizumab for atopic dermatitis, tolebrutinib for multiple sclerosis, and lifileucel for advanced melanoma.